ERNA vs. HPAI
ERNA (Eterna Therapeutics Inc) and HPAI (Helport AI Ltd) are both stocks. ERNA operates in Biotechnology (Healthcare), while HPAI operates in Software - Infrastructure (Technology). Over the past year, ERNA returned -87.57% vs -87.27% for HPAI. At a 0.02 correlation, their price movements are largely independent.
Performance
ERNA vs. HPAI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ERNA achieves a -79.80% return, which is significantly higher than HPAI's -84.55% return.
ERNA
- 1D
- 2.19%
- 1M
- -1.46%
- 6M
- -81.50%
- YTD
- -79.80%
- 1Y
- -87.57%
- 3Y*
- -81.25%
- 5Y*
- -85.57%
- 10Y*
- -62.07%
HPAI
- 1D
- -0.15%
- 1M
- -12.90%
- 6M
- -82.46%
- YTD
- -84.55%
- 1Y
- -87.27%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ERNA vs. HPAI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
ERNA Eterna Therapeutics Inc | -79.80% | -72.79% | -83.48% |
HPAI Helport AI Ltd | -84.55% | -24.32% | -53.75% |
Correlation
The correlation between ERNA and HPAI is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.02 |
Correlation (All Time) Calculated using the full available price history since Aug 5, 2024 | 0.02 |
Fundamentals
ERNA:
$1.90M
HPAI:
$24.43M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ERNA vs. HPAI — Risk / Return Rank
ERNA
HPAI
ERNA vs. HPAI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Eterna Therapeutics Inc (ERNA) and Helport AI Ltd (HPAI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ERNA | HPAI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.33 | ||
| Sortino ratioReturn per unit of downside risk | +1.19 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 0.73 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | -0.94 | -0.96 | +0.02 |
| Martin ratioReturn relative to average drawdown | -1.38 | -1.71 | +0.33 |
Loading charts...
Drawdowns
ERNA vs. HPAI - Drawdown Comparison
The maximum ERNA drawdown since its inception was -100.00%, roughly equal to the maximum HPAI drawdown of -95.65%. Use the drawdown chart below to compare losses from any high point for ERNA and HPAI.
Loading charts...
Drawdown Indicators
| ERNA | HPAI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -95.65% | -4.35% |
Max Drawdown (1Y)Largest decline over 1 year | -93.32% | -89.75% | -3.57% |
Max Drawdown (3Y)Largest decline over 3 years | -99.67% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | — | — |
Current DrawdownCurrent decline from peak | -100.00% | -94.59% | -5.41% |
Average DrawdownAverage peak-to-trough decline | -86.18% | -65.39% | -20.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 63.64% | 50.29% | +13.35% |
Volatility
ERNA vs. HPAI - Volatility Comparison
The current volatility for Eterna Therapeutics Inc (ERNA) is 26.61%, while Helport AI Ltd (HPAI) has a volatility of 40.21%. This indicates that ERNA experiences smaller price fluctuations and is considered to be less risky than HPAI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ERNA | HPAI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.61% | 40.21% | -13.60% |
Volatility (6M)Calculated over the trailing 6-month period | 130.04% | 79.59% | +50.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 151.77% | 94.59% | +57.18% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 114.08% | 104.40% | +9.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 149.04% | 104.40% | +44.64% |
Dividends
ERNA vs. HPAI - Dividend Comparison
Neither ERNA nor HPAI has paid dividends to shareholders.
Financials
ERNA vs. HPAI - Financials Comparison
This section allows you to compare key financial metrics between Eterna Therapeutics Inc and Helport AI Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ERNA and HPAI have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HPAI has higher volatility (40.21%) compared to ERNA (26.61%). In terms of maximum drawdown, ERNA dropped -100.00% vs HPAI's -95.65%.
ERNA currently has the higher Sharpe Ratio (-0.58 vs -0.91), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ERNA and HPAI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer